Ad
related to: northern health success factor 4 complex side effects
Search results
Results From The WOW.Com Content Network
Platelet factor 4 (PF4) is a small cytokine belonging to the CXC chemokine family that is also known as chemokine (C-X-C motif) ligand 4 (CXCL4) . This chemokine is released from alpha-granules of activated platelets during platelet aggregation, and promotes blood coagulation by moderating the effects of heparin -like molecules.
Fondaparinux, a factor Xa inhibitor, is commonly used off label for HIT treatment in the United States. [ citation needed ] According to a systematic review , people with HIT treated with lepirudin showed a relative risk reduction of clinical outcome (death, amputation, etc.) to be 0.52 and 0.42 when compared to patient controls.
Platelet factor 4 can cause heparin-induced thrombocytopenia. The package insert states that prothrombin complex concentrate is contraindicated in patients with disseminated intravascular coagulation, a pathological activation of coagulation, [24] because giving clotting factors would only further fuel this process. However, if the PCC is given ...
An unusual side effect of digoxin is a disturbance of color vision (mostly yellow and green) called xanthopsia. Vincent van Gogh's "Yellow Period" may have somehow been influenced by concurrent digitalis therapy. Other oculotoxic effects of digoxin include generalized blurry vision, as well as seeing a "halo" around each point of light.
Possible side effects of nicotine [2] [3] The World Health Organization and other health organisations characterise the probability of experiencing side effects as: [4] [5] Very common, ≥ 1 ⁄ 10; Common (frequent), 1 ⁄ 10 to 1 ⁄ 100; Uncommon (infrequent), 1 ⁄ 100 to 1 ⁄ 1000; Rare, 1 ⁄ 1000 to 1 ⁄ 10000; Very rare, < 1 ⁄ 10000
Northern Health is the publicly funded healthcare provider for the northern half of the Canadian province of British Columbia. Northern Health serves over 300,000 people in an area of 600,000 square kilometres. [1] It was established as one of five geographically based health authorities in 2001 by the Government of British Columbia. [2]
Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, including sarcomas, some carcinomas (e.g., small cell lung cancer, squamous cell carcinoma of the head and neck and ovarian cancer), lymphomas, bladder cancer, cervical cancer, [9] and germ cell tumors.
Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain . [ 2 ]